Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Lantheus Holdings, Inc. (LNTH) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Lantheus Holdings, Inc. (LNTH), most recent 12 months reported: revenue $1.56B, net income $275.31M, free cash flow $387.83M. Latest balance sheet on file: liquid cash $593.3M, total debt $571.05M, net cash $22.25M. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: IDEXX LABORATORIES INC /DE · QUIDELORTHO CORP · Neogen Corporation · MYRIAD GENETICS, INC. · INTELLIA THERAPEUTICS, INC. · Alpha Teknova, Inc. · ImmuCell Corporation · Anbio Biotechnology

Stock screener

Watchlist